newsfilter
← Latest News
GlobeNewswire·

ALX Oncology to Present at Upcoming Investor Conferences in September

  • ALX Oncology Holdings Inc. (NASDAQ: ALXO) announced leadership participation in fireside chats at three upcoming investor conferences.
  • The Wells Fargo 21st Annual Healthcare Conference fireside chat is scheduled for September 9, 2026, at 3:45 PM ET in Boston, MA.
  • The Cantor Global Healthcare Conference fireside chat is scheduled for September 10, 2026, at 10:20 AM ET in New York, NY.
  • The H.C. Wainwright 28th Annual Global Investment Conference fireside chat is scheduled for September 14, 2026, at 1:30 PM ET in New York, NY.
  • All three events include options for fireside chats and one-on-one meetings, with webcasts available via provided links or the company website.
  • Webcast replays will be archived for up to 90 days following each presentation date.
  • ALX Oncology's lead candidate, evorpacept, is being evaluated across multiple clinical trials for various cancer indications.
  • The second pipeline candidate, ALX2004, is an EGFR-targeted antibody-drug conjugate currently in a Phase 1 dose-escalation trial for EGFR-expressing solid tumors.
  • Investor relations contact is Kevin Lui, Director of Investor Relations, 16; media contact is Genevieve Britton, Senior Director of Public Relations.